FDA: ANDA during COVID-19 pandemic [BE/BA News]

posted by Helmut Homepage – Vienna, Austria, 2021-01-19 18:27 (1549 d 14:17 ago) – Posting: # 22183
Views: 1,967

Dear all,

last Friday the FDA’s CDER/OGD published a new guidance

Protecting Participants in
Bioequivalence Studies for
Abbreviated New Drug
Applications During the COVID-19
Public Health Emergency


Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,713 registered users;
25 visitors (0 registered, 25 guests [including 8 identified bots]).
Forum time: 09:44 CEST (Europe/Vienna)

Do not worry about your difficulties in mathematics.
I can assure you mine are still greater.    Albert Einstein

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5